Education
About Us
Working with TipRanks
Follow Us
bioAffinity Technologies, Inc. (BIAF)
NASDAQ:BIAF
RESEARCH TOOLSreports
Total Valuation
bioAffinity Technologies, Inc. has a market cap or net worth of $9.86M. The enterprise value is $14.57M.
Market Cap$9.86M
Enterprise Value$14.57M
Share Statistics
bioAffinity Technologies, Inc. has 18,255,823 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding18,255,823
Owned by Insiders24.12%
Owned by Institutions0.27%
Financial Efficiency
bioAffinity Technologies, Inc.’s return on equity (ROE) is -1.63 and return on invested capital (ROIC) is -124.25%.
Return on Equity (ROE)-1.63
Return on Assets (ROA)-0.97
Return on Invested Capital (ROIC)-124.25%
Return on Capital Employed (ROCE)-1.33
Revenue Per Employee44.43K
Profits Per Employee-139.25K
Employee Count57
Asset Turnover0.31
Inventory Turnover94.18
Valuation Ratios
The current PE Ratio of bioAffinity Technologies, Inc. is -1.62. bioAffinity Technologies, Inc.’s PEG ratio is 0.03.
PE Ratio-1.62
PS Ratio0.46
PB Ratio2.65
Price to Fair Value2.65
Price to FCF-2.12
Price to Operating Cash Flow-2.13
PEG Ratio0.03
Income Statement
In the last 12 months, bioAffinity Technologies, Inc. had revenue of 2.53M and earned -7.94M in profits. Earnings per share was -0.91.
Revenue2.53M
Gross Profit791.62K
Operating Income-7.97M
Pretax Income-7.92M
Net Income-7.94M
EBITDA-7.63M
Earnings Per Share (EPS)-0.91
Cash Flow
In the last 12 months, operating cash flow was -7.20M and capital expenditures -65.64K, giving a free cash flow of -7.27M billion.
Operating Cash Flow-7.20M
Free Cash Flow-7.27M
Free Cash Flow per Share-0.40
Dividends & Yields
bioAffinity Technologies, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-2.71
52-Week Price Change-80.24%
50-Day Moving Average0.51
200-Day Moving Average1.24
Relative Strength Index (RSI)48.62
Average Volume (3m)19.56M
Important Dates
bioAffinity Technologies, Inc. upcoming earnings date is May 20, 2025, TBA Not Confirmed.
Last Earnings DateMar 31, 2025
Next Earnings DateMay 20, 2025
Ex-Dividend Date―
Financial Position
bioAffinity Technologies, Inc. as a current ratio of 1.77, with Debt / Equity ratio of 55.09%
Current Ratio1.77
Quick Ratio1.76
Debt to Market Cap0.00
Net Debt to EBITDA0.16
Interest Coverage Ratio-214.77
Taxes
In the past 12 months, bioAffinity Technologies, Inc. has paid 20.99K in taxes.
Income Tax20.99K
Effective Tax Rate>-0.01
Enterprise Valuation
bioAffinity Technologies, Inc. EV to EBITDA ratio is -1.52, with an EV/FCF ratio of -1.92.
EV to Sales4.59
EV to EBITDA-1.52
EV to Free Cash Flow-1.92
EV to Operating Cash Flow-1.92
Balance Sheet
bioAffinity Technologies, Inc. has $756.58K in cash and marketable securities with $10.01M in debt, giving a net cash position of $962.82K billion.
Cash & Marketable Securities$756.58K
Total Debt$10.01M
Net Cash$962.82K
Net Cash Per Share$0.05
Tangible Book Value Per Share$0.30
Margins
Gross margin is 31.85%, with operating margin of -314.84%, and net profit margin of -313.41%.
Gross Margin31.85%
Operating Margin-314.84%
Pretax Margin-312.58%
Net Profit Margin-313.41%
EBITDA Margin-301.26%
EBIT Margin-311.11%
Analyst Forecast
The average price target for bioAffinity Technologies, Inc. is $6.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$6.00
Price Target Upside1100.00% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast269.68%
EPS Growth Forecast17.26%